ERBB2 and breast cancer: Consistent with the previous report (37), the morphology and size of lesions varied with the expression of different hormone receptors, and hormone receptor-negative plus HER2-positive or TNBC breast cancers tend to have larger lesions than hormone HR+/Luminal cancers.